Oxford Global Conferences are proud to present the 5th Annual Biosimilars & Biobetters Congress co-located with the 11th Annual Proteins & Antibodies Congress and the 5th Annual Peptides Congress, taking place on the 16-17 April 2018 in London.
Over 450 proteins, peptides and biosimilars delegates representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions
Over 20 presentations and case studies focusing on the key areas of the biosimilars industry including market access strategies, clinical development, commercialisation, manufacturing and bio-analytics
Two-day interactive conference addressing the following topics:
View Agenda here: http://bit.ly/2eFkKL6
Biosimilars: Everyday Practice, Manufacturing Pre-Clinical Trials
Hosted by Katalin Egyed, International Oncology and Onco-biotechnology Business Unit Manager, EGIS Pharmaceuticals and Rafał Derlacz, Senior Project Manager, Polpharma.
Wednesday 7th February 2018 | 10am GMT
Register today for free: http://bit.ly/2xNJGbG
Biosimilars: The Cancer Patient Perspective
Hosted by Lydia Makaroff, Director, European Cancer Patient Coalition
Tuesday 13th February 2018 | 10am GMT
Register today for free: http://bit.ly/2j1vAAf
Can’t make the dates? Still register and a copy of the webinar recording will be sent to you.
For further information, prices & discounts please contact firstname.lastname@example.org
Oxford Global is proud to present the 3rd Annual Advances in Immuno-Oncology Congress taking place on 24–25 May 2018 in London, UK, featuring over 50 presentations in a revamped conference programme that ensures you will benefit from the latest case studies and high-level scientific debate.
Discussion ranges across a variety of therapeutic strategies, from the discovery of combination therapies to vaccines to checkpoint inhibitors. Further talks look at genomic approaches to cancer immunotherapy and the impact of growing microbiome research on immuno-oncology.
6 interactive streams:
View the Agenda here: http://bit.ly/2oJlVB7
Key Speakers include Chief Executives and Directors from AstraZeneca, Merck, GlaxoSmithKline, Glycostem and many more. The two-day congress offers an interactive platform for high level scientific and business discussions, ensuring valuable networking and interactive sessions.
Free Pre-Congress Live Webinars
Novel Checkpoint Inhibitors & Strategies for Combined Modality Treatment
Hosted by Geert Mudde, Founder and Chief Scientific Officer, TYG Oncology Ltd.
Register today, for free: http://bit.ly/2mGZNmO
Personalised Medicine and Immuno-Oncology
Hosted by Agnete Fredriksen, Chief Scientific Officer, Vaccibody
Register today, for free: http://bit.ly/2rigNFh
Can’t make the dates? Still register and a copy of the webinar recording can be sent to you.
For further information about the programme, prices & discounts please contact email@example.com
Join Oxford Global’s 19th Annual Drug Discovery Summit on the 7- 8th June 2018 in Berlin, Germany to explore the latest innovations pushing industry to new heights. This congress will cover such areas as innovation, enabling technologies, new modalities and novel drug targets as well as covering key areas such as phenotypic screening, genome based drug discovery and small molecule drug discovery.
Bringing together over 300 senior level peers, the congress is once again co-located with our 6th Annual Discovery Chemistry and Drug Design Congress. Delegates can expect to hear updates on discovery, medicinal and computational chemistry as well as medicinal chemistry in drug design. New for 2018 we’ll be including deep dive sessions on DNA encoded libraries as well as presentations on data visualisation, protein-protein interactions and protein degradation.
VIEW AGENDA: http://bit.ly/2mqWK5m
Drug Discovery Summit Streams:
Discovery Chemistry & Drug Design Congress Streams:
Oxford Global is proud to present the 2nd Annual Microbiome Discovery and Development Congress, taking place on the 7-8th June 2018 in Berlin, Germany. The conference showcases world-class senior industry experts presenting case studies on the most exciting issues in the microbiome field, covering novel strategies in microbiome research, the latest therapeutic trends, and the challenges and opportunities involved in commercialising microbiome therapeutics.
View Agenda: http://bit.ly/2BOsODK
The congress will cover 2 areas focusing on:
Further sessions will focus on subjects including bioinformatics, translational modelling, genomic approaches, IP concerns, investment in the microbiome, the gut-brain axis and autoimmune disorders. The two-day congress offers an interactive platform for high level scientific and business discussions, ensuring valuable networking and interactive sessions.
2018 Microbiome Webinar:
Microbiome-Directed Therapeutics to tackle metabolic disorders
Hosted by Sandrine Claus, Chief Scientific Officer, LNC Therapeutics
Register for Free Now: http://bit.ly/2j0IqvO
For more information about our programme and to register for the congress, please contact Guillaume Alonso at firstname.lastname@example.org.
Join Oxford Global for the 2nd Annual Precision Medicine Congress, 11-12 June 2018, Munich as our panel of over 40 world class speakers discuss the latest regulatory updates, biomarker developments, information technologies and companion diagnostics for personalized therapies.
View Agenda: http://bit.ly/2BF20WZ
Across two days, our event will bring together over 200 senior level attendees from academia, research institutes and pharma companies to discuss the current challenges and future perspectives of precision medicine. Over 40 presentations and case studies focusing on the key developments in precision medicine regulation, biomarkers, clinical development, digital technologies and diagnostics.
4 interactive streams:
2018 Live Webinar:
Precision Medicine & Cancer Genomics – Clinical And Pharmaceutical Applications
Hosted by Dr Honey Reddi, The Jackson Laboratory and Dr Michael Menden, AstraZeneca.
Register for Free Now: http://bit.ly/2F8bytZ
2017 Free Webinar Recording:
Clinical Utility of Genomic Testing
Hosted by Elaine Lyon, Professor, University of Utah & Medical Director of Molecular Genetics, ARUP Laboratories.
Download for Free: http://bit.ly/2B3TOOO